WMDH yields 2000000.00% · PFE yields 6.13%● Live data
📍 WMDH pulled ahead of the other in Year 1
Combined, WMDH + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WMDH + PFE for your $10,000?
WMD Holdings Group, Inc. engages in the development and deployment of turnkey solutions for financial and payment processing, prepaid services, telecommunications, and interactive broadcasting networks in the United States. The company offers NAVITOUCH, an interactive broadcast network system that enables worldwide broadcasting of interactive content and advertising to various touch screen monitors; local and long-distance telephone services; and financial, payment, and communication services through its point of sale terminals, which facilitate the recharge and distribution of a multitude of pre-paid offerings, including pre-paid debit cards, pre-paid wireless distribution, and pre-paid long distance. It also provides debit card solutions; closed loop stored value and gift card programs; check cashing and bill payment services; cell phone sales; shipping; and money transfers. In addition, WMD Holdings offers payday advances and loans to consumers requiring emergency funding, short term bridge loans, and advances on payroll. It primarily distributes its solutions through a combination of company owned and operated locations, online, and other independent sales organizations to the financial, payment processing, telecommunications, and advertising industries. The company was founded in 2001 and is based in Huntington Beach, California.
Full WMDH Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.